✦ LIBER ✦

Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties

✍ Scribed by J.-W. Tian; W.-L. Jiang; Y. Zhong; Q. Meng; Y. Gai; H.-B. Zhu; J. Hou; Y. Xing; Y.-X. Li

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and Clinical Pharmacology of

✍ Phil Skolnick; Philip Krieter; Joseph Tizzano; Anthony Basile; Piotr Popik; Pal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Preclinical pharmacology of F-98214-TA,

✍ Inés Artaiz; Arturo Zazpe; Ana Innerárity; Elena del Olmo; Alvaro Díaz; José Ang 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 255 KB

Preclinical Pharmacology of a Novel Dual

✍ Allan, Geoffrey ;Cambridge, David ;Follenfant, Michael J. ;Hardy, George W. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 757 KB

Preclinical pharmacology profile of CS-7

✍ Shigeru Ushiyama; Tomoko Yamada; Yukiko Murakami; Sei-ichiro Kumakura; Shin-ichi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Characterization of the Potent 5-HT1A /B

✍ Jeannette M. Watson; Lee A. Dawson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Escitalopram, theS-(+)-enantiomer of cit

✍ C. Sánchez; P. B. F. Bergqvist; L. T. Brennum; S. Gupta; S. Hogg; A. Larsen; O. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 358 KB